New IPO filings include NGM, Arog, Gamida

Three biotechs filed late Sept. 28 to go public on NASDAQ, adding new companies to a 2018 class of IPOs that could surpass 2015's record for funds raised. The group includes NGM Biopharmaceuticals Inc. (South San Francisco, Calif.), Arog Pharmaceuticals Inc. (Dallas, Tex.) and Gamida Cell Ltd. (Jerusalem, Israel) (see "Paper Chase").

NGM, a liver disease and metabolic

Read the full 570 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE